MeSH tree: G02.111.820
A research team at the University of Würzburg has gained new insights into the development of kidney tumors in young children. These enable a better risk assessment and could form the basis for targeted screening and improved ...
May 27, 2025
0
26
Tumor cells in colorectal cancer exploit an important signaling pathway that normally controls embryo development. Researchers have now shown how a protein that controls the development of the arms and heart contributes to ...
May 22, 2025
0
41
Duke University Medical Center-led research has identified a human-specific DNA enhancer that regulates neural progenitor proliferation and cortical size. Small genetic changes in HARE5 amplify a key developmental pathway, ...
Neurodevelopmental disorders are a diverse group of conditions that affect the brain from early development. They include attention-deficit hyperactivity disorder (ADHD), autism and learning disabilities, such as dyslexia.
May 19, 2025
0
17
Dental caries (tooth decay) is a common oral health condition that often causes significant pain and discomfort and may even lead to tooth loss. In severe and untreated cases, bacterial infection combined with the host's ...
May 8, 2025
0
41
In a study published in Advanced Science, researchers from the Institute of Biophysics of the Chinese Academy of Sciences, along with collaborators at the Institutes of Brain Science and Fudan University, have developed an ...
Apr 23, 2025
0
29
A common pinworm medication may stop and reverse cancer growth in Merkel cell carcinoma, an aggressive form of skin cancer, according to research led by University of Arizona Cancer Center researchers and published in the ...
Apr 18, 2025
0
91
A Ludwig Cancer Research study has identified a novel strategy for treating acute myelogenous leukemia (AML), an aggressive blood cancer for which the median survival time following diagnosis remains just 8.5 months.
Apr 16, 2025
0
26
New research from the Royal Veterinary College (RVC) has identified porcupine inhibition—a strategy that blocks a key bone-related signaling pathway (Wnt)—as a promising pharmacological treatment for severe sclerosteosis.
Apr 15, 2025
0
41
New studies in rats suggest the drug reserpine, approved in 1955 for high blood pressure, might treat the blinding disease retinitis pigmentosa. No therapy exists for this rare inherited disease, which starts affecting vision ...
Apr 15, 2025
0
16
